KORU Medical Systems Inc.
Last updated September 27, 2026
Organization details
- Legal name
- KORU Medical Systems Inc.
- Former names
- Repro MED Systems Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Mahwah
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KRMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000704440
- EIN
- 13-3044880
Board of directors
-
Donna French · DirectorSince 2023
-
Edward Wholihan · DirectorSince 2023
-
James M. Beck · DirectorSince 2023
-
Joseph M. Manko Jr. · DirectorSince 2023
-
Linda M. Tharby · Director · Chief Executive OfficerSince 2023
-
R. John Fletcher · DirectorSince 2023
-
Robert Cascella · DirectorSince 2023
-
Shahriar Matin · DirectorSince 2023
Chief executives
Linda M. Tharby
· President and CEO
Dates unknown
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.5%
-
98.4%
-
99.2%
-
99.8%
-
99.8%
-
99.8%
Board connections
3 of this board's directors also sit on 6 other boards.
- via Robert Cascella
- via R. John Fletcher
- via Robert Cascella
- via Joseph M. Manko Jr.
- via Robert Cascella
- via Joseph M. Manko Jr.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,629,074
- 8 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | KALBERMATTEN ADAM R Officer (Chief Commercial Officer) | Open-market purchase | +32,000 | $3.16 | $101,120 |
| Jul 28, 2026 | KALBERMATTEN ADAM R Officer (Chief Commercial Officer) | Option exercise | +75,000 | — | — |
| Jul 28, 2026 | KALBERMATTEN ADAM R Officer (Chief Commercial Officer) | Shares withheld for tax | −25,483 | $4.26 | $108,558 |
| Jul 1, 2026 | Robert Cascella Director | Grant or award | +3,571 | $4.20 | $14,998 |
| Jul 1, 2026 | R. John Fletcher Director, Chairman of the Board | Grant or award | +5,357 | $4.20 | $22,499 |
| Jul 1, 2026 | Donna French Director | Grant or award | +3,571 | $4.20 | $14,998 |
| Jul 1, 2026 | Shahriar Matin Director | Grant or award | +3,571 | $4.20 | $14,998 |
| Jul 1, 2026 | Edward Wholihan Director | Grant or award | +3,571 | $4.20 | $14,998 |
| Jun 30, 2026 | Joseph M. Manko Jr. Director, 10% owner | Grant or award | +3,571 | — | — |
| Jun 11, 2026 | KALBERMATTEN ADAM R Officer (President-Chief Commercial Off) | Open-market purchase | +5,000 | $3.96 | $19,800 |
| Jun 11, 2026 | KALBERMATTEN ADAM R Officer (President-Chief Commercial Off) | Open-market purchase | +7,500 | $3.93 | $29,475 |
| May 18, 2026 | Schiller Eric Officer (Chief Technology Officer) | Open-market purchase | +5,000 | $3.91 | $19,550 |
| May 15, 2026 | Linda M. Tharby Director, Officer (Chief Executive Officer) | Open-market purchase | +1,191 | $1,191.00 | $1,418,481 |
| May 14, 2026 | Linda M. Tharby Director, Officer (Chief Executive Officer) | Option exercise | +13,977 | — | — |
| May 14, 2026 | Pazdan Christopher Officer (Chief Operating Officer) | Option exercise | +5,327 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.